Kumar, A. H. “Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy”. Biology, Engineering, Medicine and Science Reports, vol. 7, no. 2, Oct. 2021, pp. 21-24, doi:10.5530/bems.7.2.8.